The potential for selective pharmacological therapies through biased receptor signaling
出版年份 2012 全文链接
标题
The potential for selective pharmacological therapies through biased receptor signaling
作者
关键词
-
出版物
BMC Pharmacology & Toxicology
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2012-08-13
DOI
10.1186/2050-6511-13-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biased Signaling Pathways in 2-Adrenergic Receptor Characterized by 19F-NMR
- (2012) J. J. Liu et al. SCIENCE
- A Simple Method for Quantifying Functional Selectivity and Agonist Bias
- (2011) Terry Kenakin et al. ACS Chemical Neuroscience
- Cardiorenal Actions of TRV120027, a Novel ß-Arrestin–Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines
- (2011) Guido Boerrigter et al. Circulation-Heart Failure
- Crystal structure of the β2 adrenergic receptor–Gs protein complex
- (2011) Søren G. F. Rasmussen et al. NATURE
- Functional Selectivity and Biased Receptor Signaling
- (2010) T. Kenakin JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Selectively Engaging -Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance
- (2010) J. D. Violin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
- (2010) T. Kenakin et al. PHARMACOLOGICAL REVIEWS
- β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
- (2009) Robert W. Walters et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic Deletion of p90 Ribosomal S6 Kinase 2 Alters Patterns of 5-Hydroxytryptamine2A Serotonin Receptor Functional Selectivity
- (2009) R. T. Strachan et al. MOLECULAR PHARMACOLOGY
- A -Arrestin-Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
- (2009) D. Gesty-Palmer et al. Science Translational Medicine
- Gα-Subunits Differentially Alter the Conformation and Agonist Affinity of κ-Opioid Receptors†
- (2008) Feng Yan et al. BIOCHEMISTRY
- Kinetics of G-protein-coupled receptor signals in intact cells
- (2008) M J Lohse et al. BRITISH JOURNAL OF PHARMACOLOGY
- Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer
- (2008) Jian Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular determinants of angiotensin II type 1 receptor functional selectivity
- (2008) Mark Aplin et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Selectivity of Agonists for the Active State of M1 to M4 Muscarinic Receptor Subtypes
- (2008) K. W. Figueroa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Fluorescence Resonance Energy Transfer Analysis of 2a-Adrenergic Receptor Activation Reveals Distinct Agonist-Specific Conformational Changes
- (2008) A. Zurn et al. MOLECULAR PHARMACOLOGY
- Conformational Rearrangements and Signaling Cascades Involved in Ligand-Biased Mitogen-Activated Protein Kinase Signaling through the 1-Adrenergic Receptor
- (2008) S. Galandrin et al. MOLECULAR PHARMACOLOGY
- Agonist-directed signaling of the serotonin 2A receptor depends on -arrestin-2 interactions in vivo
- (2008) C. L. Schmid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic cells
- (2008) N. Sonoda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling
- (2007) Teodora Georgieva et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started